Cboe, Citadel Securities and Healthy Markets Sue CFTC Over Stock Perpetuals

Cboe, Citadel Securities, and Healthy Markets sued the CFTC over its approval of perpetual derivatives tied to individual US stocks, arguing they should be classified as security-based swaps under SEC oversight. A judge questioned the CFTC's authority but denied an emergency halt. The case involves KalshiEX, Bitnomial Exchange, and Coinbase Derivatives, with a preliminary injunction request pending.

Original reporting
Published Nov 6, 2026, 6:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 7:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cboe, Citadel Securities and Healthy Markets Sue CFTC Over Stock Perpetuals — source image
Decision brief

The 30-second read

$CBOEBearishMed
01

Why it matters

The legal challenge creates uncertainty for firms that rely on these new products for revenue and could influence broader regulatory approaches to crypto‑inspired derivatives.

02

Market read

The lawsuit may affect pricing and investor sentiment for listed exchanges involved in crypto‑style perpetual contracts.

03

What to watch

Potential for other exchanges to launch similar products outside the contested framework, diluting the lawsuit's effect.

Relevance 7/10Novelty 7/10Timing: immediate (article date 2026-11-06)

Background

A coalition of industry participants has filed a lawsuit challenging the CFTC's authority to approve stock perpetual futures, arguing they should be regulated as security‑based swaps.

Company-level read

Ticker impact

$CBOEBearishHigh confidence
Context

Cboe Global Markets is a named plaintiff in the lawsuit challenging CFTC's approval of stock perpetual contracts.

Expected impact

likely downside pressure as market prices in potential restrictions on stock perpetuals.

Evidence & confidence

The lawsuit directly targets Cboe's ability to list these derivatives, creating legal and operational risk.

$COINBearishHigh confidence
Context

Coinbase Derivatives is listed as one of the exchanges whose stock perpetual approvals are being contested.

Expected impact

potential short-term pressure as investors assess the impact of the legal challenge.

Evidence & confidence

The lawsuit could limit Coinbase's ability to offer perpetual contracts, a growing revenue source.

Market effects

Derivatives and crypto‑related trading platforms may see increased scrutiny and slower product roll‑outs.

U.S. equity and crypto markets could experience heightened volatility amid regulatory uncertainty.

The case may set precedent for how U.S. regulators treat crypto‑style perpetual products worldwide.

Counterpoint

If the court ultimately sides with the CFTC, the lawsuit could be a short‑term distraction with limited long‑term impact.

Key entities

  • Cboe Global Markets

    U.S. exchange listed as plaintiff

  • Coinbase

    Crypto exchange with a derivatives arm named in the suit

Related articles

$COINMed

Coinbase has news for gold holders

Coinbase now allows customers to borrow USDC against PAX Gold, a token backed by physical gold. The loans, powered by Morpho and built on Base, are available in the U.S. except New York. PAXG is issued by Paxos Trust Company, with each token backed by one troy ounce of gold. Coinbase sponsors network fees, and loans can be repaid at any time, with rates set by supply and demand. Loan originations on the exchange have surpassed $1 billion.

$COINHigh

Morgan Stanley downgrades Coinbase, cuts target by more than half

Morgan Stanley downgraded Coinbase to underweight, cutting its price target to $120 from $258, citing weakened earnings recovery confidence. Analyst Michael Cyprys reduced revenue forecasts for 2027 and 2028 by 28% and 18%, respectively, and lowered 2027 adjusted EBITDA estimate by 47%. The downgrade follows a recent Binance hack and sluggish crypto trading. Coinbase's Q4 transaction revenue is expected to miss analyst estimates by 11%.

$COINMed

Coinbase Enables Borrowing Against Gold via Morpho

Coinbase now allows users to borrow USDC against gold (PAXG) via Morpho, adding to existing crypto collateral options. The service is available in the U.S. except New York. Morpho reports $3.4B in collateral and $1.7B in active loans on the platform. The liquidation loan-to-value ratio is 77%, with loan-health updates during gold-market hours.

$CRCLMed

Circle Sinks 12%, Coinbase and Strategy Tumble 10% as Bitcoin Slide Hits Crypto Stocks

Circle Internet (CRCL) fell 12% to $67.25 despite an upgrade and earnings beat. Coinbase (COIN) and Strategy (MSTR) dropped 10% each as Bitcoin (BTC) declined 6% in 24 hours. Circle's Q3 EPS of $0.84 beat estimates, but revenue fell 11% YoY excluding a token presale. Coinbase's Q3 revenue dropped 35% YoY. Bitcoin's slide and broader market sell-off impacted these crypto-linked stocks.

$CBOEMed

Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC over its approval of single-stock perpetual derivatives. The CMA argues these products should fall under SEC jurisdiction and that the CFTC violated the Administrative Procedure Act. The CMA seeks to vacate the approvals, but a judge denied an emergency restraining order, indicating the CMA may succeed in its claim. The CFTC and CMA are set to respond by November 6 and 10, respectively.